Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Programmed Intermittent Bolus | Active Comparator | 6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus |
|
| Continuous Infusion | Active Comparator | 6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Programmed Intermittent Bolus | Other | 6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus |
|
| Measure | Description | Time Frame |
|---|---|---|
| Opioid consumption 24 hours postoperatively | morphine equivalents of opioids in mg will be obtained from medical record | first 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Opioid consumption 48 hours postoperatively | morphine equivalents of opioids in mg will be obtained from medical record | first 48 hours postoperatively |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elird Bojaxhi, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D013896 | Thoracic Diseases |
| ID | Term |
|---|---|
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Investigators will not have direct access to settings on the pump
| Continuous Infusion | Other | 6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion |
|